跳至主要内容
临床试验/ACTRN12607000064404
ACTRN12607000064404已完成3 期

Trans Tasman Radiation Oncology Group (TROG) 03.08 - A phase III international randomized trial of single versus multiple fractions for re-irradiation of painful bone metastases from any cancer to increase pain relief

ational Cancer Insitute of Canada0 个研究点目标入组 850 人开始时间: 2004年7月28日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
850

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Patient must have histologically or cytologically proven malignancy. Histological diagnosis may be established from needle biopsy, bone marrow biopsy, cytology, or a surgical biopsy or resection. All malignant histologies/cytologies are eligible. 2. Plain radigraphs, radionuclide bone scans, CT scans and/or magnetic resonance imaging confirm the presence of bone metastatses corresponding to clinically painful area.

排除标准

  • 1. Clinical or radiological evidence of spinal cord compression at the time of assessment for this study.2. Clinical or radiological evidence of pathological fractures of extremities in the area to be re-irradiated.3. The treatment area has received prior palliative surgery.4. There is planned surgical intervention on the treated bone.

研究者

发起方
ational Cancer Insitute of Canada

相似试验